PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Breast Cancer and Financial Toxicity: What Patients Need to Know. A breast cancer diagnosis creates many immediate questions:
What stage is my cancer? What treatment will I need? What are my chances of recurrence? What side effects should I expect?
There is another question that deserves to be asked much earlier than it usually is:
What is breast cancer going to cost me and my family?
Researchers use the term financial toxicity to describe the financial problems and distress caused by cancer and cancer treatment.
Financial toxicity can include much more than hospital bills. It can mean:
And breast cancer may present a particularly important financial challenge because treatment can involve several different therapies spread over months or even years.
A patient might undergo surgery followed by chemotherapy and radiation, followed by years of endocrine therapy. Other patients may require HER2-targeted drugs, immunotherapy, reconstruction, rehabilitation, surveillance imaging, or ongoing treatment for metastatic disease.
In other words, the financial side effect of breast cancer may continue long after the initial treatment ends.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. Though my cancer was different from breast cancer, I learned that cancer is about much more than just chemo, radiation, surgery, and immunotherapy. I stared at EOB envelopes from my health insurance company piling up on my desk… unopened. Big mistake.
I have come to believe that therapy-induced side effects, like financial toxicity, can be life-threatening while ruining quality of life.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about financial toxicity.
Good luck,
The National Cancer Institute defines financial toxicity as problems related to the cost of medical care.
Cancer patients can experience three overlapping types of financial hardship:
| Type of Financial Toxicity | Examples |
|---|---|
| Material | Medical debt, depleted savings, difficulty paying bills |
| Psychological | Anxiety, worry and stress about money |
| Behavioral | Skipping medications, delaying appointments or changing care because of cost |
This last category may be particularly important.
Financial toxicity isn’t simply about losing money.
Financial toxicity can potentially interfere with cancer treatment itself.
Patients facing high costs sometimes delay medical care, fail to fill prescriptions or take less medication than prescribed.
That makes financial toxicity a health issue as well as an economic issue.
Breast cancer frequently requires multimodal treatment, meaning several different forms of therapy may be used.
Depending on the cancer, these can include:
A 2025 review in the American Society of Clinical Oncology Educational Book highlighted several reasons breast cancer patients can be particularly vulnerable to financial toxicity.
These include multimodal treatment, years of hormonal therapy for some patients, employment disruption, caregiving responsibilities and the cumulative costs associated with long-term survivorship.
When patients think about the cost of breast cancer, they understandably think first about medical bills.
But medical bills are only part of the equation.
These can include:
These expenses can be less visible but equally damaging:
For some families, lost income may become as important as medical expenses.
Lumpectomy and mastectomy can involve surgeon, hospital, anesthesia and pathology charges.
Breast reconstruction may involve additional procedures and recovery periods.
Time away from work during recovery creates another potential financial burden.
Chemotherapy can create both direct and indirect costs.
Beyond the cost of the drugs themselves, patients may face:
Side effects such as fatigue, neuropathy or cognitive problems may also make working difficult.
Radiation often requires treatment five days a week for several weeks, although shorter treatment schedules are increasingly used for appropriate patients.
Even when each appointment is relatively short, repeated travel, parking and time away from work can create substantial indirect costs.
Women with hormone-receptor-positive breast cancer may take endocrine therapy for five years or longer.
The monthly prescription cost may seem relatively modest compared with surgery or chemotherapy, but years of copays and follow-up appointments can accumulate.
Cost becomes particularly important if it contributes to medication non-adherence.
Some patients with HER2-positive, triple-negative or metastatic breast cancer may receive expensive targeted therapies or immunotherapies.
Treatment can continue for months or, in metastatic disease, potentially much longer.
Patients should ask about expected out-of-pocket costs before treatment begins whenever possible.
Financial toxicity can affect anyone with breast cancer—even someone with good health insurance.
However, research suggests that risk can be greater among:
Younger women may face additional pressures involving childcare, fertility preservation, mortgages, education expenses and interruptions during important earning years.
One of the most important misconceptions about cancer treatment is:
“I have health insurance, so most of this will be covered.”
Insurance can protect patients from catastrophic medical expenses, but it doesn’t necessarily eliminate:
This is why patients should understand their health insurance benefits as early as possible after diagnosis.
See: How Much Does Cancer Cost After Insurance?
Cancer patients are accustomed to asking questions about treatment effectiveness and side effects.
Cost should become another routine treatment question.
Consider asking:
“Approximately what will this treatment cost me out of pocket?”
Then ask:
These questions are not about choosing inferior cancer treatment because it is cheaper.
They are about understanding the clinical benefit, side effects and financial consequences of the available options.
One of the most practical steps a newly diagnosed breast cancer patient can take is to ask:
“Does this cancer center have a financial navigator or oncology social worker?”
Financial navigators may help patients:
The key is timing.
Don’t wait until medical debt becomes overwhelming before asking for help.
Financial navigation may be most useful when it begins near the start of treatment.
See: Cancer Financial Navigators: What They Do and How They Help.
Financial assistance can come from several sources:
Eligibility requirements vary considerably.
Some programs help with medications while others may help with transportation, lodging, utilities, or household expenses.
See: Cancer Grants and Financial Assistance Programs: How to Find Help Paying for Cancer Care.
Financial toxicity often develops gradually.
Warning signs can include:
If any of these begin happening, tell your oncology team.
Financial distress is relevant medical information.
Finishing chemotherapy or radiation does not necessarily mean the financial burden is finished.
Breast cancer survivors may continue paying for:
Some survivors also experience persistent changes in employment or income.
This is one reason I believe financial recovery should become part of cancer survivorship planning.
Breast cancer treatment should not be evaluated only in terms of tumor response and physical side effects.
Patients also deserve to understand the financial side effects of treatment.
For some breast cancer patients, treatment may last months. For others, endocrine therapy or metastatic treatment can continue for years.
That means financial toxicity can become a long-term side effect of breast cancer.
The best time to address financial toxicity is before it becomes a financial crisis.
Ask about treatment costs.
Understand your insurance.
Talk with a financial navigator.
Investigate grants and assistance programs.
And if cost is making it difficult for you to take a medication or receive recommended care, tell your oncology team rather than silently changing your treatment.
Protecting your financial health is part of protecting your overall quality of life during and after breast cancer.